| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/30/1998 | WO1998032451A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 07/30/1998 | WO1998032435A1 Liquid eye drop composition |
| 07/30/1998 | WO1998032421A1 Ophthalmic compositions including glycerin and propylene glycol |
| 07/30/1998 | WO1998027108A3 New amide compounds and their use as nitric oxide synthase inhibitors |
| 07/30/1998 | CA2456777A1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
| 07/30/1998 | CA2279241A1 Mammalian thioredoxin |
| 07/30/1998 | CA2278779A1 Substituted amino bicyclic-.beta.-lactam penam and cepham derivatives as cysteine protease inhibitors |
| 07/30/1998 | CA2278152A1 Treatment of autoimmune disease using tolerization in combination with methotrexate |
| 07/30/1998 | CA2228017A1 A drug preparation for oral administration |
| 07/29/1998 | EP0855182A1 3-Deoxyglucosone production inhibitor |
| 07/29/1998 | EP0854868A1 Substituted hydroisoquinoline derivatives and their use as pharmaceuticals |
| 07/29/1998 | EP0854711A1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 07/29/1998 | EP0749428B1 Isoxazoline compounds as inhibitors of tnf release |
| 07/29/1998 | EP0740668B1 Tetracyclic derivatives, process of preparation and use |
| 07/29/1998 | EP0717732B1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
| 07/29/1998 | CN1189186A OMP 26 antigen from haemophilus influenzae |
| 07/29/1998 | CN1189166A Somatostatin peptides |
| 07/28/1998 | US5786379 Adamantyl-substituted biaromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 07/28/1998 | US5786363 Aqueous compositions containing ciprofloxacine, and related use |
| 07/28/1998 | US5786355 4,6-diarylpyrimidine derivatives and salts thereof |
| 07/28/1998 | US5786197 lep |
| 07/28/1998 | CA2141563C Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 07/23/1998 | WO1998031709A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/23/1998 | WO1998031702A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/23/1998 | WO1998031664A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
| 07/23/1998 | WO1998031660A1 Process for preparing indane-like compounds |
| 07/23/1998 | WO1998031359A1 Integrin antagonists |
| 07/23/1998 | DE19701607A1 Anitkörper, die an die Nidogen-Bindungsdomäne des Laminins binden, deren Herstellung und Verwendung Anitkörper that bind to the nidogen-binding domain of laminin, their preparation and use |
| 07/23/1998 | CA2278477A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/23/1998 | CA2278424A1 Process for preparing indane-like compounds |
| 07/23/1998 | CA2277924A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/22/1998 | EP0854145A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0854140A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0853661A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 07/22/1998 | EP0853476A2 Pharmaceutical preparation containing nimesulide for topical use |
| 07/22/1998 | EP0766695B1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 07/22/1998 | EP0748312B1 Bicyclic carbamates as leukotriene d4 antagonists |
| 07/21/1998 | US5783184 Administering monoclonal antibodies |
| 07/16/1998 | WO1998030707A2 Eukaryotic gene expression cassette and uses thereof |
| 07/16/1998 | WO1998030551A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNFα SECRETION |
| 07/16/1998 | WO1998021181A3 15-fluoro prostaglandins as ocular hypotensives |
| 07/16/1998 | CA2278326A1 Eukaryotic gene expression cassette and uses thereof |
| 07/15/1998 | EP0696190B1 Nasal aromatic releasing compositions |
| 07/15/1998 | CN1187486A Difluoroprostaglundin Derivatives and their use |
| 07/14/1998 | US5780592 Transplant, antitumor |
| 07/14/1998 | US5780498 Endothelin receptor antagonists |
| 07/09/1998 | WO1998029417A1 Cyclic organoselenium compounds, their preparation and their uses |
| 07/09/1998 | WO1998029119A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | WO1998029090A1 Moistening preparation |
| 07/09/1998 | WO1998028980A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | CA2276150A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | CA2276081A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | CA2274909A1 Cyclic organoselenium compounds, their preparation and their uses |
| 07/08/1998 | EP0851875A2 Dna sequences and secreted proteins encoded thereby |
| 07/08/1998 | CN1187123A Treatment for ocular inflammation |
| 07/07/1998 | US5776968 Therapeutic uses of melanin |
| 07/07/1998 | US5776704 Method of detecting angiogenic protein |
| 07/07/1998 | US5776489 Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
| 07/07/1998 | CA2033243C Phenylethanolaminomethyltetralins |
| 07/02/1998 | WO1998028301A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 07/02/1998 | WO1998028292A1 Novel piperidine containing compounds |
| 07/02/1998 | WO1998028265A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 07/02/1998 | WO1998027974A1 Antidiabetic agents |
| 07/02/1998 | WO1998027973A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
| 07/02/1998 | CA2275681A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
| 07/02/1998 | CA2275665A1 Nitromethylthiobenzene derivatives as aldose reductase inhibitors |
| 07/02/1998 | CA2275394A1 Antidiabetic agents |
| 07/02/1998 | CA2275312A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 07/01/1998 | EP0850926A2 Difluoroprostaglandin derivatives and their use |
| 07/01/1998 | EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents |
| 07/01/1998 | EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | EP0850236A1 Piperazino derivatives as neurokinin antagonists |
| 07/01/1998 | CN1186518A Human vascular endothelial growth factor 2 |
| 07/01/1998 | CN1186515A 转化生长因子αHI Transforming growth factor αHI |
| 07/01/1998 | CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | CN1186431A Compositions and methods using nitroxides in combination with biocompatible macromolecules |
| 07/01/1998 | CN1185948A Inhibitor for generation of 3-deoxyglucurone |
| 07/01/1998 | CN1038939C Preparation of peptide compounds |
| 06/30/1998 | US5773654 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these compounds |
| 06/30/1998 | US5773646 Integrin inhibitors |
| 06/30/1998 | US5773609 In vivo target tissue selectivity |
| 06/30/1998 | US5773472 Method and means for prevention of cataract |
| 06/30/1998 | US5773452 Alzheimer's disease; cognition activators |
| 06/30/1998 | US5773440 Antiinflammatory agent |
| 06/30/1998 | US5773019 Inner core containing an effective amount of a low solubility agent covered by a non-bioerodible polymer coating layer that is permeable to the low solubility agent |
| 06/27/1998 | CA2225906A1 3-deoxyglucosone production inhibitor |
| 06/25/1998 | WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors |
| 06/25/1998 | WO1998026784A1 A method for preventing or controlling cataract |
| 06/25/1998 | WO1998026782A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications |
| 06/25/1998 | WO1998026777A1 Ophtalmic viscoelastic compositions |
| 06/25/1998 | WO1998026770A2 The topical use of kappa opioid agonists to treat ocular pain |
| 06/25/1998 | WO1998022101A3 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 06/25/1998 | WO1998021182A3 Use of cis-δ4 analogs of prostaglandins as ocular hypotensives |
| 06/25/1998 | WO1998019649A3 Methods and compositions for inhibition of angiogenesis |
| 06/25/1998 | CA2273480A1 Ophtalmic viscoelastic compositions |
| 06/24/1998 | EP0848952A1 Use of lower alkanoyl l-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies |
| 06/24/1998 | CN1185736A Use of thiazolium compounds for preventing and preverting the formation of advanced glycosylation endproducts |
| 06/23/1998 | US5770628 Eye disorders |
| 06/23/1998 | US5770624 Inhibitors of tumor necrosis factor alpha and matrix degrading metalloproteinease activity |
| 06/23/1998 | US5770607 Aqueous liquid composition for external use |